当前位置：
X-MOL 学术
›
Helicobacter
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention
Helicobacter ( IF 4.3 ) Pub Date : 2022-06-15 , DOI: 10.1111/hel.12911 Jing Ma 1 , Miao Yu 1 , Qiao-Qiao Shao 1 , Xue-Chun Yu 1 , Chen Zhang 1 , Jun-Bo Zhao 1 , Lin Yuan 1 , Ya-Bin Qi 1 , Ruo-Bing Hu 1 , Pei-Ru Wei 1 , Wei Xiao 1 , Qi Chen 2 , Bai-Ling Jia 1 , Chuan-Liang Chen 3 , Hong Lu 4 , Song-Ze Ding 1
Helicobacter ( IF 4.3 ) Pub Date : 2022-06-15 , DOI: 10.1111/hel.12911 Jing Ma 1 , Miao Yu 1 , Qiao-Qiao Shao 1 , Xue-Chun Yu 1 , Chen Zhang 1 , Jun-Bo Zhao 1 , Lin Yuan 1 , Ya-Bin Qi 1 , Ruo-Bing Hu 1 , Pei-Ru Wei 1 , Wei Xiao 1 , Qi Chen 2 , Bai-Ling Jia 1 , Chuan-Liang Chen 3 , Hong Lu 4 , Song-Ze Ding 1
Affiliation
Helicobacter pylori (H. pylori) infection and its related diseases are substantial public health burden for highly infected areas. Recently, a novel family-based H. pylori infection control and management (FBCM) strategy is introduced for H. pylori infection prevention and control. However, its cost-effectiveness has not been evaluated. We conducted this health economic evaluation to investigate the cost-effectiveness of FBCM, screen-and-treat, and no-screen strategies in Chinese population.
更新日期：2022-06-15
京公网安备 11010802027423号